SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011462
Filing Date
2024-08-08
Accepted
2024-08-08 07:15:35
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trvn-20240630x10q.htm   iXBRL 10-Q 1548277
2 EX-31.1 trvn-20240630xex31d1.htm EX-31.1 16918
3 EX-31.2 trvn-20240630xex31d2.htm EX-31.2 16048
4 EX-32.1 trvn-20240630xex32d1.htm EX-32.1 8912
5 EX-32.2 trvn-20240630xex32d2.htm EX-32.2 9256
  Complete submission text file 0001558370-24-011462.txt   7427931

Data Files

Seq Description Document Type Size
6 EX-101.SCH trvn-20240630.xsd EX-101.SCH 56056
7 EX-101.CAL trvn-20240630_cal.xml EX-101.CAL 51039
8 EX-101.DEF trvn-20240630_def.xml EX-101.DEF 211095
9 EX-101.LAB trvn-20240630_lab.xml EX-101.LAB 486469
10 EX-101.PRE trvn-20240630_pre.xml EX-101.PRE 354289
72 EXTRACTED XBRL INSTANCE DOCUMENT trvn-20240630x10q_htm.xml XML 1352021
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 241186025
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)